Literature DB >> 29979949

Quality of life and sexual functıon in obese women with pelvic floor dysfunction.

Dilek Bilgic1, Sule Gokyildiz2, Nezihe Kizilkaya Beji3, Onay Yalcin4, Funda Gungor Ugurlucan4.   

Abstract

This prospective study was conducted in the urogynecology and gynecology outpatient clinics of Istanbul Faculty of Medicine from December 2014 to March 2015. The objective was to identify the association between obesity and sexual function and quality of life in women with pelvic floor dysfunction (PFD). A total of 387 sexually active women diagnosed with urinary incontinence and/or pelvic organ prolapse were included and categorized as obese (n = 200) or nonobese (n = 187). Mean body mass indexes were 25.7 ± 2.41 kg/m2 for nonobese women and 34.9 ± 3.92 kg/m2 for obese women. The Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12 total score was significantly lower in obese (27.66 ± 7.12) than in nonobese women (30.18 ± 6.54) (p < .05). Quality of life mean scores were higher in obese women for both the Incontinence Impact Questionnaire total score (67.24 ± 26.8 versus 49.12 ± 27.5) and Urogenital Distress Inventory total score (65.02 ± 21.4 versus 55.07 ± 24.7) (p < .001). Obese women with PFD had symptoms for longer durations, had more frequent urinary incontinence, and worse sexual function and quality of life than nonobese women. Health-care professionals caring for obese women should be aware of the coexistence of obesity and PFD. Future studies should evaluate whether obesity-associated PFD can be reduced through successful weight reduction interventions.

Entities:  

Keywords:  Obesity; pelvic floor dysfunction; quality of life; sexual function; urinary incontinence; women’s health

Mesh:

Year:  2018        PMID: 29979949     DOI: 10.1080/03630242.2018.1492497

Source DB:  PubMed          Journal:  Women Health        ISSN: 0363-0242


  7 in total

1.  Obesity and its long-term impact on sacrocolpopexy key outcomes (OBELISK).

Authors:  Martin Smazinka; Vladimir Kalis; Martin Havir; Linda Havelkova; Khaled M Ismail; Zdenek Rusavy
Journal:  Int Urogynecol J       Date:  2019-08-08       Impact factor: 2.894

2.  Association Between Body Mass Index and Female Sexual Dysfunction: A Cross-sectional Study from the Data Registry on Experiences of Aging, Menopause, and Sexuality.

Authors:  Stephanie S Faubion; Flavia Fairbanks; Carol L Kuhle; Richa Sood; Juliana M Kling; Jennifer A Vencill; Kristin C Mara; Ekta Kapoor
Journal:  J Sex Med       Date:  2020-08-06       Impact factor: 3.802

3.  Effect of Body Weight on Sexual Function in Men and Women.

Authors:  Jenna N Bates; Alexander W Pastuszak; Mohit Khera
Journal:  Curr Sex Health Rep       Date:  2019-01-19

4.  Impact of biofeedback therapy for pelvic floor-related constipation to improve sexual function.

Authors:  Seyedshahab Banihashem; Nasrin Chalakinia; Pegah Eslami; Mehran Mahdavi Roshan; Ali Kheradmand; Saeed Abdi; Somayeh Motazedian; Maryam Nasserinejad; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020

Review 5.  The effect of women's body mass index on pelvic organ prolapse: a systematic review and meta analysis.

Authors:  Chernet Baye Zenebe; Wagaye Fentahun Chanie; Aster Berhe Aregawi; Tamiru Minwuye Andargie; Muhabaw Shumye Mihret
Journal:  Reprod Health       Date:  2021-02-19       Impact factor: 3.223

Review 6.  Multidisciplinary management of women with pelvic organ prolapse, urinary incontinence and lower urinary tract symptoms.A clinical and psychological overview.

Authors:  Valentina Lucia La Rosa; Michał Ciebiera; Li-Te Lin; Zaki Sleiman; Tais Marques Cerentini; Patricia Lordelo; Ilker Kahramanoglu; Simone Bruni; Simone Garzon; Michele Fichera
Journal:  Prz Menopauzalny       Date:  2019-11-05

7.  Association of Self-Reported Physical Fitness with Pregnancy Related Symptoms the GESTAFIT Project.

Authors:  Nuria Marín-Jiménez; Milkana Borges-Cosic; Olga Ocón-Hernández; Irene Coll-Risco; Marta Flor-Alemany; Laura Baena-García; José Castro-Piñero; Virginia A Aparicio
Journal:  Int J Environ Res Public Health       Date:  2021-03-24       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.